Current treatments to prevent organ transplant rejection focus mainly on suppressing T cells, part of the adaptive immune ...

Influenza viruses are among the most likely triggers of future pandemics. A research team from the Helmholtz Center for ...

Studies show how spike protein changes determine the risk of viral outbreaks, offering important insights for the future ...

Sarcopenia, a hallmark of cancer cachexia, is associated with poor outcomes in chimeric antigen receptor (CAR) T-cell therapy ...

Let us delve into some of the TLR agonists in the clinic and why the careful selection of these drugs is crucial.

Non-Aspergillus invasive molds infections (NAIMIs) are uncommon but devastating causes of infection in the peri-hematopoietic ...

Immunocore reports first quarter financial results and provides a business update KIMMTRAK® (tebentafusp-tebn) net revenues of $93.9 million in Q1 2025, growing by 33% year-over-year ...

DelveInsight’s Non-Hodgkin Lymphoma pipeline report depicts a robust space with 200+ Non-Hodgkin Lymphoma companies working ...

Newly discovered oncology drugs called “DNA-encoded tri-specific T-cell engagers,” or “DTriTEs,” engage the immune system ...

This explainer outlines how neurons and glial cells coordinate electrical and chemical signals to form complex brain networks that govern thought, behavior, and consciousness. It also explores how ...

Parkinson’s disease disrupts lives by slowly robbing people of their ability to move, speak, and function with ease. It's the ...

Cancer scientists engineer a new type of antibody which could be used to boost the immune systems of patients fighting disease.